
Screening Shortfalls and Self-Collected Samples
Is at-home sample collection the solution to lagging cancer screening uptake—or does this approach introduce a new set of challenges?
Is at-home sample collection the solution to lagging cancer screening uptake—or does this approach introduce a new set of challenges?
With US STI cases continuing to climb to numbers not seen in decades, a recent FDA approval comes at an opportune moment.
The national retailer recently signed a deal with Simple HealthKit to provide Walmart customers online access to at-home diagnostic test kits.
No company better embodies the vicissitudes of running a COVID-19-focused diagnostics business during the pandemic period than Lucira Health.
A research team has developed a new, simpler microfluidic chip that could make at-home diagnosis of diseases faster and more affordable